drugset / Trial / NCT00212901
High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
RandomizedCrossoverOpen-label
Summary
Investigation of wheather addition of angiotensin receptor blocker (Irbesartan) to recommended doses of angiotensin converting enzyme inhibitor (trandolapril) is more effective in decreasing amount of protein in urine in patients with diabetic kidney disease than high doses of trandolapril.
Timeline
- Start
- 2004-08
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irbesartan | Small molecule | — | — |
| Subject | trandolapril | Small molecule | — | — |